Clinical Trial Results:
A single-centre, randomised, double-blind, two-way crossover, placebo-controlled pilot study, investigating the use of a novel intragastric and oesophageal pH catheter to characterise the antacid activity of Gaviscon Double Action Liquid in the fasted state followed by a preliminary investigation of the effects of food.
Summary
|
|
EudraCT number |
2011-004725-27 |
Trial protocol |
GB |
Global completion date |
24 May 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Nov 2016
|
First version publication date |
12 Nov 2016
|
Other versions |
|
Summary report(s) |
2011-004725-27 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.